Nj State Employees Deferred Compensation Plan Zai Lab LTD Transaction History
Nj State Employees Deferred Compensation Plan
- $761 Million
- Q1 2025
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Zai Lab LTD stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 11,300 shares of ZLAB stock, worth $459,119. This represents 0.05% of its overall portfolio holdings.
Number of Shares
11,300
Previous 11,300
-0.0%
Holding current value
$459,119
Previous $295,000
38.31%
% of portfolio
0.05%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding ZLAB
# of Institutions
175Shares Held
52.2MCall Options Held
92.9KPut Options Held
318K-
Capital World Investors Los Angeles, CA6.01MShares$244 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X03.81MShares$155 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.65MShares$148 Million0.03% of portfolio
-
Clearbridge Investments, LLC New York, NY3.28MShares$133 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY3.14MShares$127 Million1.86% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.98B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...